
    
      Participants will undergo screening for study, if eligible, participants will be dosed with
      15 million or 30 million cells will be administered via IA delivery with interventional
      radiology. Participant study visits after study intervention includes visits on: Day 1, Week
      1, Week 2, Week 8, Week 24, Week 52, and Week 104.
    
  